You just read:

Aldeyra Therapeutics Announces First Patient Enrolled in the RENEW Phase 3 Clinical Trial for Dry Eye Disease

News provided by

Aldeyra Therapeutics, Inc.

Apr 02, 2019, 08:00 ET